Showing results (331-340 of 444) with videos related to

Sort By:
Pageof 45
American Journal of Respiratory and Critical Care Medicine|February 14, 2024
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE TrialLuca Richeldi, Courtney Schiffman, Jürgen Behr, et al.
Vaccines|April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung CancerEmanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2022
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial)Fernando J Martinez, Marlies S Wijsenbeek, Ganesh Raghu, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2024
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease ProgressionEnrico De Lorenzis, Francesco Del Galdo, Gerlando Natalello, et al.
The Lancet. Respiratory Medicine|March 9, 2020
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U Wells, Kevin R Flaherty, Kevin K Brown, et al.
The European Respiratory Journal|March 26, 2026
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trialMarlies S Wijsenbeek, Shervin Assassi, Arata Azuma, et al.
The Lancet. Respiratory Medicine|September 5, 2020
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research prioritiesPeter M George, Paolo Spagnolo, Michael Kreuter, et al.
Tuberculosis (Edinburgh, Scotland)|April 5, 2011
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosisMorten Ruhwald, Jose Dominguez, Irene Latorre, et al.
BMJ Open Respiratory Research|March 10, 2026
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trialWim A Wuyts, Lisa Lancaster, Toby M Maher, et al.
Elife|February 21, 2022
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosisChristopher J Brereton, Liudi Yao, Elizabeth R Davies, et al.
Pageof 45